MedTrace Logo

Supraglottic Airways for Entrapped Trauma Patients

NCT06545903 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-05-06

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate four supraglottic airway devices for ventilation in a simulated condition of an entrapped trauma patient with simultaneous cervical spine immobilisation. All the studied devices are evaluated by fully-qualified and experienced paramedics (both male and female). The main questions it aims to answer are:

1. Which device requires the shortest time required to achieve a successful ventilation?
2. What is the first attempt success rate of the studied devices?
3. Which device is the easiest to use and the most user-friendly? Study participants will evaluate four different supraglottic devices in a restricted access to the entrapped trauma patient's airway. The maximum number of insertion attempts is limited to three per device.

Conditions

  • Airway Obstruction

Interventions

DEVICE

LMA Supreme

The device is inserted and the manikin ventilated

DEVICE

SLIPA

The device is inserted and the manikin ventilated

DEVICE

I-gel

The device is inserted and the manikin ventilated

DEVICE

AuraGain

The device is inserted and the manikin ventilated

Sponsors & Collaborators

  • Uniwersytet Radomski im. Kazimierza Pułaskiego

    lead OTHER

Principal Investigators

  • Dawid J Aleksandrowicz, PhD · University of Radom

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-09-01
Completion
2025-05-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06545903 on ClinicalTrials.gov